NCT05904392

Brief Summary

Introduction Ocular intravitreal injection is a widely used ophthalmic invasive technique to administer medication directly inside the patient's eye. Despite being usually a quick and painless intervention, some patients report nervousness and anxiety before and during the procedure. Music therapy could help in assessing this discomfort, as previous studies have shown it can beneficial, specially helping to reduce anxiety levels. Objective This study aims to assess the effect of music therapy on patients undergoing intravitreal injections and how it affects their anxiety. Methods This is a randomized, prospective, single blind, clinical trial. Patients will be divided into two groups. Group A patients will listen to classical music during the procedure (intervention). Group B patients (control), will not listen to music during the procedure. All other aspects of the procedure will be the same for both groups. To analyze the impact music therapy, patients will fill in the STAI anxiety questionnaire and will be evaluated with the pain visual analogue scale (VAS) before and after the injection procedure. Expected results Subjects that undergo the procedure with music therapy are expected to experience less anxiety that the ones that do not. Less pain perception is also expected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

2 months

First QC Date

May 28, 2023

Last Update Submit

March 4, 2024

Conditions

Keywords

Music therapyanxietyintravitreal injectionpainquality of life

Outcome Measures

Primary Outcomes (1)

  • STAI

    Change in anxiety score test

    Just before and immediately after intervention

Study Arms (2)

Intervention

EXPERIMENTAL

Music played prior to intravitreal injection

Other: Music

Control

NO INTERVENTION

No music played.

Interventions

MusicOTHER

Music played prior to injection

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be at least 18 years old.
  • Patients must have been prescribed an intravitreal injections of an anti-VEGF drug.
  • Subjects must have undergone at least one previous intravitreal injection.
  • Patients must fully understand the procedure and the project they will be participating in and agree on signing the informed consent.

You may not qualify if:

  • Patients with a psychiatric diagnosis with the need to take anxiety medication.
  • Patients that before the intervention took medication to relax, such as benzodiazepines or anxiolytics.
  • Subjects with hearing difficulty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eduard Pedemonte Sarrias

Manresa, Barcelona, 08243, Spain

Location

MeSH Terms

Conditions

Anxiety DisordersPain

Interventions

Music Therapy

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

May 28, 2023

First Posted

June 15, 2023

Study Start

December 1, 2023

Primary Completion

January 31, 2024

Study Completion

February 28, 2024

Last Updated

March 5, 2024

Record last verified: 2024-03

Locations